An Overview on Probiotics as an Alternative Strategy for Prevention and Treatment of Human Diseases

被引:10
作者
Taherian, Mahdi [1 ,2 ]
Samadi, Pariya Mahin [3 ]
Rastegar, Hossein [4 ]
Faramarzi, Mohammad Ali [5 ,6 ]
Rostami-Nejad, Mohammad [7 ]
Yazdi, Mohammad Hossein [3 ,8 ,9 ]
Rezaei-Tayirani, Mostafa [10 ]
Yazdi, Zeinab [11 ]
机构
[1] Minist Hlth & Med Educ MOH, Iran Food & Drug Org FDO, Food & Drug Lab Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Dept Med Genet, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Biotechnol Res Ctr, Fac Pharm, Tehran, Iran
[4] Minist Hlth & Med Educ MOH, Food & Drug Cosmet Res Ctr, Iran Food & Drug Org FDO, Tehran, Iran
[5] Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut Biotechnol, Tehran, Iran
[6] Univ Tehran Med Sci, Fac Pharm, Biotechnol Res Ctr, Tehran, Iran
[7] Shahid Beheshti Univ Med Sci, Gastroenterol & Liver Dis Res Ctr, Res Inst Gastroenterol & Liver Dis, Tehran, Iran
[8] Univ Tehran Med Sci, Recombinant Vaccine Res Ctr, Tehran, Iran
[9] Univ Tehran Med Sci, Evidence Based Evaluat Cost Effectiveness & Clin, Inst Pharmaceut Sci TIPS, Tehran, Iran
[10] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Prote Res Ctr, Tehran, Iran
[11] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2019年 / 18卷
关键词
Probiotics; Cancer; Immune Responses; Treatment; Diabetes mellitus; Multiple sclerosis; LACTIC-ACID BACTERIA; DIET-INDUCED OBESITY; GUT-MICROBIOTA; INTESTINAL MICROBIOTA; COLORECTAL-CANCER; OXIDATIVE STRESS; BREAST-CANCER; T-CELLS; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL;
D O I
10.22037/ijpr.2020.112232.13620
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Probiotics are viable and useful microorganisms, which are beneficial factors for human and animal health by altering their microbial flora. Most of the probiotics belong to a large group of bacteria in the human gastrointestinal tract. There are several clinical shreds of evidence that show anti-carcinogenic effects of probiotics through altering digestive enzymes, inhibition of carcinogenic agents, and modulating the immune responses in experimental animals Many studies have been performed to evaluate the potential effectiveness of probiotics in treating or preventing neurological diseases such as MS and novel treatment modality for T1D. The purpose of this study is to have an overview on probiotic microorganisms and to review the previous researches on the effects of probiotics on health through currently available literatures. The study was performed using following keywords; Probiotics, Cancer, Immune system, Multiple Sclerosis (MS) and Diabetes mellitus. PubMed/Medline, Clinicaltrials.gov, Ovid, Google Scholar, and Reaxcys databases used to find the full text of related articles. According to the current available data on probiotics and related health-promoting benefits, it seems that, consumption of probiotics can lead to the prevention and reduction the risk of cancer, diabetes, and multiple sclerosis. Although for the better and more decisive conclusion, there is a need to larger sample size clinical studies with more focus on the safety of these biological agents and their possible beneficial effects on different population.
引用
收藏
页码:31 / 50
页数:20
相关论文
共 137 条
  • [1] Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat distal colon cells
    Abrahamse, SL
    Pool-Zobel, BL
    Rechkemmer, G
    [J]. CARCINOGENESIS, 1999, 20 (04) : 629 - 634
  • [2] Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies
    Al-Attas, Omar S.
    Al-Daghri, Nasser M.
    Al-Rubeaan, Khalid
    da Silva, Nancy F.
    Sabico, Shaun L.
    Kumar, Sudhesh
    McTernan, Philip G.
    Harte, Alison L.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2009, 8
  • [3] Al-Salami H, 2008, EUR J DRUG METAB PH, V33, P101
  • [4] Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota
    Alard, Jeanne
    Lehrter, Veronique
    Rhimi, Moez
    Mangin, Irene
    Peucelle, Veronique
    Abraham, Anne-Laure
    Mariadassou, Mahendra
    Maguin, Emmanuelle
    Waligora-Dupriet, Anne-Judith
    Pot, Bruno
    Wolowczuk, Isabelle
    Grangette, Corinne
    [J]. ENVIRONMENTAL MICROBIOLOGY, 2016, 18 (05) : 1484 - 1497
  • [5] Alyanakian MA, 2006, DIABETES, V55, P179, DOI 10.2337/diabetes.55.01.06.db05-0189
  • [6] Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
    Amar, Jacques
    Chabo, Chantal
    Waget, Aurelie
    Klopp, Pascale
    Vachoux, Christelle
    Bermudez-Humaran, Luis G.
    Smirnova, Natalia
    Berge, Mathieu
    Sulpice, Thierry
    Lahtinen, Sampo
    Ouwehand, Arthur
    Langella, Philippe
    Rautonen, Nina
    Sansonetti, Philippe J.
    Burcelin, Remy
    [J]. EMBO MOLECULAR MEDICINE, 2011, 3 (09) : 559 - 572
  • [7] Probiotics, prebiotics and colorectal cancer prevention
    Ambalam, Padma
    Raman, Maya
    Purama, Ravi Kiran
    Doble, Mukesh
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2016, 30 (01) : 119 - 131
  • [8] Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc11-S011, 10.2337/dc13-S067, 10.2337/dc10-S011, 10.2337/dc13-S011, 10.2337/dc11-S062, 10.2337/dc14-S081, 10.2337/dc12-s011, 10.2337/dc10-S062, 10.2337/dc12-s064]
  • [9] Amer LD, 2014, TISSUE ENG PART B-RE, V20, P455, DOI [10.1089/ten.TEB.2013.0462, 10.1089/ten.teb.2013.0462]
  • [10] [Anonymous], 2007, Glial Neurobiology: A Textbook